TNON
Tenon Medical, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$3.72
−1.33%Aug 28, 2026, 12:15 UTC
Tenon Medical entered into a securities purchase agreement to sell 597,610 shares of common stock (or pre-funded warrants) and warrants for up to 1,058,517 shares in a private placement at a combined effective price of $5.02 per share.
Aug 14, 2026, 01:57 UTC
Tenon Medical plans to launch sacropelvic products over the next six to nine months following FDA 510(k) clearance.
Source:Aug 13, 2026, 20:05 UTC
Tenon Medical received FDA 510(k) clearance for its updated Catamaran SI Joint Fusion System.
Source:Aug 13, 2026, 20:05 UTC
Tenon Medical reported second quarter 2026 revenue of $1.3 million, a 127% increase from $0.6 million in the prior year, and gross profit of $0.8 million with a 64% gross margin.
Aug 6, 2026, 12:30 UTC
Tenon Medical, Inc. announced a 1-for-35 reverse stock split of its common stock, effective August 10, 2026.
Source:Jun 30, 2026, 13:25 UTC
Tenon Medical, Inc. priced a public offering of common stock and warrants for aggregate gross proceeds of approximately $4.2 million.